RE:RE:RE:RE:RE:RE:Dear Prince of fraudulance bashing
RBS, as you appear to be a full on luving rube i will give you this tidbit to know "cancer trials showing efficacy on an end point of progression-free survival but not overall survival"...the puzzle piece i am still working on is the impact of unmet need on "skinny" submissions. ya see IMO the FDA will have to violate just about all of its standard standards here and it will be based building a strong "unmet need" case if that can in fact be done...but keep entertaining me i deserve it